Evidence map›Paper›PMID 34848489›Full record

ArticleDiabetes care2022

Evidence That Hypothalamic Gliosis Is Related to Impaired Glucose Homeostasis in Adults With Obesity.

Jennifer L Rosenbaum, Susan J Melhorn, Stefan Schoen, Mary F Webb, Mary Rosalynn B De Leon, Madelaine Humphreys, Kristina M Utzschneider, Ellen A Schur

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Hypothalamic neuronal-glial crosstalk in metabolic disease.npj metabolic health and disease · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jennifer L RosenbaumDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA.
Susan J MelhornDivision of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA.
Stefan SchoenUniversity of Washington School of Medicine, Seattle, WA.
Mary F WebbDivision of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA.
Mary Rosalynn B De LeonDivision of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA.
Madelaine HumphreysDivision of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA.
Kristina M UtzschneiderDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA.
Ellen A SchurDivision of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA.ORCID 0000-0002-1013-0795
University of Washington · US

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
VIRAL VECTOR COREP30DK019525 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MITCHELL A. LAZAR · 1986 to 2026
$48.3M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Tomas Vaisar · 1986 to 2026
$41.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
Nutrition, Obesity and Atherosclerosis Training ProgramT32HL007028 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1985 to 2026
$6.4M
A twin study of obesity pathogenesis using fMRIR01DK089036 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCHUR, ELLEN A · 2011 to 2022
$6.2M
Impact of hypothalamic gliosis on appetite regulation and obesity risk in childrenR01DK117623 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCHUR, ELLEN A · 2019 to 2023
$3.7M
Fostering patient-oriented research in cardiometabolic disease pathogenesis and preventionK24HL144917 · NHLBI · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 2019 to 2026
$965k
NCATS NIH HHS UL1 TR002319NHLBI NIH HHS K24 HL144917NHLBI NIH HHS T32 HL007028NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK019525NIDDK NIH HHS P30 DK035816NIDDK NIH HHS R01 DK089036NIDDK NIH HHS R01 DK117623
6 · The paper itself

Abstract

objectivePreclinical research implicates hypothalamic glial cell responses in the pathogenesis of obesity and type 2 diabetes (T2D). In the current study we sought to translate such findings to humans by testing whether radiologic markers of gliosis in the mediobasal hypothalamus (MBH) were greater in individuals with obesity and impaired glucose homeostasis or T2D. RESEARCH DESIGN AND

methodsUsing cross-sectional and prospective cohort study designs, we applied a validated quantitative MRI approach to assess gliosis in 67 adults with obesity and normal glucose tolerance, impaired glucose tolerance (IGT), or T2D. Assessments of glucose homeostasis were conducted via oral glucose tolerance tests (OGTT) and β-cell modeling.

resultsWe found significantly greater T2 relaxation times (a marker of gliosis by MRI), that were independent of adiposity, in the groups with IGT and T2D as compared with the group with normal glucose tolerance. Findings were present in the MBH, but not control regions. Moreover, positive linear associations were present in the MBH but not control regions between T2 relaxation time and glucose area under the curve during an OGTT, fasting glucose concentrations, hemoglobin A1c, and visceral adipose tissue mass, whereas negative linear relationships were present in the MBH for markers of insulin sensitivity and β-cell function. In a prospective cohort study, greater MBH T2 relaxation times predicted declining insulin sensitivity over 1 year.

conclusionsFindings support a role for hypothalamic gliosis in the progression of insulin resistance in obesity and thus T2D pathogenesis in humans.

Indexed as

Diabetes Mellitus, Type 2Glucose IntoleranceInsulin ResistanceBlood GlucoseCross-Sectional StudiesGliosisGlucoseHomeostasisHumansInsulinObesityProspective StudiesBlood GlucoseGlucoseInsulin

Identifiers

PMID34848489
PMCPMC8914420
OpenAlexW3215310369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.